Home / Sweden / SynAct Pharma AB
SynAct Pharma AB
Short position disclosed on August 19, 2026.
0.72% of the capital sold short
1 disclosing fund
20 disclosures on record
SE0008241491 ISIN code
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Oct 2025Jan 2026Apr 2026Jul 2026
September 12, 2023 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Securities (Europe) Limited | 0.72% | +0.21 pt | August 19, 2026 |
On the other side: the funds that hold SynAct Pharma AB Titelia
Get the moves on SynAct Pharma AB by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
Download 20 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.99% of the capital sold short
- Elekta AB (publ) 9.12% of the capital sold short
- JM AB 7.52% of the capital sold short
- Bonesupport Holding AB 6.69% of the capital sold short
- Truecaller AB 6.51% of the capital sold short
- Hemnet Group AB (publ) 6.13% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.41% of the capital sold short
- Dynavox Group AB 4.57% of the capital sold short
- RaySearch Laboratories AB (publ) 4.36% of the capital sold short
- Aktiebolaget Electrolux 4.32% of the capital sold short
- AAK AB (publ) 4.23% of the capital sold short
- Mips AB 3.82% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, SynAct Pharma AB, source Finansinspektionen, data as at August 19, 2026, https://www.quivad.com/action/synact-pharma-ab